Cargando…
L-Norvaline, a new therapeutic agent against Alzheimer’s disease
Growing evidence highlights the role of arginase activity in the manifestation of Alzheimer’s disease (AD). Upregulation of arginase was shown to contribute to neurodegeneration. Regulation of arginase activity appears to be a promising approach for interfering with the pathogenesis of AD. Therefore...
Autores principales: | Polis, Baruh, Srikanth, Kolluru D., Gurevich, Vyacheslav, Gil-Henn, Hava, Samson, Abraham O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557086/ https://www.ncbi.nlm.nih.gov/pubmed/31089055 http://dx.doi.org/10.4103/1673-5374.255980 |
Ejemplares similares
-
L-Norvaline Reverses Cognitive Decline and Synaptic Loss in a Murine Model of Alzheimer’s Disease
por: Polis, Baruh, et al.
Publicado: (2018) -
Norvaline Restores the BBB Integrity in a Mouse Model of Alzheimer’s Disease
por: Polis, Baruh, et al.
Publicado: (2019) -
Arginase Inhibition Supports Survival and Differentiation of Neuronal Precursors in Adult Alzheimer’s Disease Mice
por: Polis, Baruh, et al.
Publicado: (2020) -
Reports of L-Norvaline Toxicity in Humans May Be Greatly Overstated
por: Polis, Baruh, et al.
Publicado: (2019) -
Norvaline Reduces Blood Pressure and Induces Diuresis in Rats with Inherited Stress-Induced Arterial Hypertension
por: Gilinsky, Michael A., et al.
Publicado: (2020)